RGCC North America

Call Directions Website Contact the business

RGCC North America RGCC was launched in 2004 by genetics pioneer Dr. Ioannis Papasotiriou with a view to developing personalized treatment options to treat cancer effectively.

RGCC North America provides individualized cellular and molecular laboratory analyses for licensed healthcare practitioners, offering observations under defined analytical conditions. Today, RGCC is a global organization, working in collaboration with branch offices and distributors to provide services worldwide. Our North America team is driven by a profound commitment to advancing the field of personalized cancer care. Our goal is simple yet powerful: to empower people facing cancer with tailored insights that can change the course of their journey. The team has extensive expertise in developing and providing personalized cancer genetics tests for doctors and patients that include testing cancer cells for sensitivity and resistance to chemotherapy treatment and a large range of natural substances. In addition to personalized cancer testing, our team is actively involved in pharmaceutical research, identifying novel targets for new drug development. Contact us today to know how we can help you in your cancer journey. https://myrgcc.com/contact-us/

RGCC Laboratory Analyses: Overview 🔬🧬 RGCC offers laboratory tests that document cellular, molecular, genomic, immune-re...
10/21/2026

RGCC Laboratory Analyses: Overview 🔬🧬

RGCC offers laboratory tests that document cellular, molecular, genomic, immune-related, and microbiome-associated characteristics using specialized analytical methods.

The portfolio includes laboratory analyses focused on:


🔵 Circulating tumor cell phenotypic markers
🔵 In vitro cellular response evaluation
🔵 Gene-expression analysis
🔵 Genomic characterization
🔵 Immune-related observations

All analyses are laboratory evaluations that generate scientific data.

Learn more about how practitioners can utilize our laboratory tests, preparations, and practitioner resources at https://myrgcc.com.

For educational purposes only. Not medical advice.

📢 RGCC North America is a sponsor of the Center for New Medicine Open House on Friday, October 23, in Irvine, California...
10/20/2026

📢 RGCC North America is a sponsor of the Center for New Medicine Open House on Friday, October 23, in Irvine, California.

The Center for New Medicine was founded by Dr. Leigh Erin Connealy, Medical Director and an RGCC-certified practitioner.

RGCC representatives will be available at the event to discuss laboratory methods and quality systems. 🔬🧪

For educational purposes only. Not medical advice.

📢 RGCC North America will be in attendance at the 2026 ILADS Annual Scientific Conference. The conference brings togethe...
10/14/2026

📢 RGCC North America will be in attendance at the 2026 ILADS Annual Scientific Conference.

The conference brings together practitioners, researchers, and scientific professionals for presentations and discussion across current research topics relevant to Lyme and associated vector-borne illnesses.

RGCC North America's participation reflects its ongoing involvement in scientific and professional education.

Event details:

🗓️ Oct 22nd – 25th, 2026
📍Herndon, VA

https://membercompass.ilads.org/events/2026-ilads-annual-scientific-conference
Learn more about how practitioners can utilize our laboratory tests, preparations, and practitioner resources at https://myrgcc.com.

For educational purposes only. Not medical advice.

10/09/2026

What Is the Epithelial Mesenchymal Transition (EMT)?

What happens when cancer cells undergo the epithelial mesenchymal transition (EMT)?

In this educational clip, Dr. Ghen discusses how cells can transition from an EpCAM-positive state to an EpCAM-negative state and why this biological process is important to understand when studying circulating tumor cells (CTCs).

The discussion also explores how EMT-related changes may affect detection methods that rely on epithelial markers.

🩺 RGCC will be attending the 2026 Midwest Functional Medicine Symposium Presented by Forum Health in partnership with Po...
10/05/2026

🩺 RGCC will be attending the 2026 Midwest Functional Medicine Symposium

Presented by Forum Health in partnership with Power2Practice, this event brings together professionals in integrative and functional medicine spaces to explore advances in research and protocols.

Event Details:

📅 Oct 10th, 2026
📍Oak Brook, IL
https://midwestfunctionalmedicinesymposium.com



Learn more about RGCC’s laboratory tests and preparations at https://myrgcc.com.



Not medical advice. For informational purposes only.

💉 We’ll be at VIBE 2026 in Las Vegas this year. Join us at Caesars Palace as we connect with medical and wellness practi...
09/30/2026

💉 We’ll be at VIBE 2026 in Las Vegas this year.

Join us at Caesars Palace as we connect with medical and wellness practitioners, industry innovators, and business leaders to share research and insights relevant to vitamin infusion and integrative wellness spaces.

📅 October 9th–11th, 2026
📍 Caesars Palace, Las Vegas, NV
🔗 https://vibexpo.com

Learn more about RGCC's laboratory analyses, preparations, and practitioner resources at https://myrgcc.com.

Not intended as medical advice. For informational purposes only.

📢 We’ll be attending the Fall 2026 AAMP Conference: Chronic Disease Epidemic - Advanced Applications. Hosted by Advanced...
09/26/2026

📢 We’ll be attending the Fall 2026 AAMP Conference: Chronic Disease Epidemic - Advanced Applications.

Hosted by Advanced Applications in Medical Practice (AAMP), this conference brings together experts and specialists to tackle one of medicine's pressing challenges — the chronic disease epidemic.

📅 October 2nd–4th, 2026
📍 Scottsdale, Arizona
🔗 https://aampconferences.com

Visit https://myrgcc.com to learn more about RGCC's laboratory analyses, preparations, and practitioner resources.

Not intended as medical advice. For informational purposes only.

🔬 RGCC will be attending the 2026 Microbiome Keynotes Symposium in Nashville, TN, September 25th–27th. Join us as we con...
09/22/2026

🔬 RGCC will be attending the 2026 Microbiome Keynotes Symposium in Nashville, TN, September 25th–27th.

Join us as we connect with experts in functional medicine and discuss the latest research on the microbiome. We look forward to networking, learning, and sharing insights with the community.

📍Nashville, TN
🗓️ September 25th–27th, 2026
🔗 https://microbiomekeynotes.com

Learn more about RGCC’s laboratory tests and preparations for functional medicine practitioners at https://myrgcc.com.

Not intended as medical advice. For informational purposes only.

09/17/2026

Not All Circulating Tumor Cells Appear Alone

This segment explores the concept of cellular clustering and examines how different cell populations may exhibit distinct biological characteristics and behaviors.

Want to continue the discussion? Dr. Ghen’s next lecture on the subject is coming up soon! DM us for details.

Primary Topics:
Cellular clusters
Cellular heterogeneity
Circulating tumor cells
Population characteristics

Join us for two days on chronic inflammatory illness in November 🌴🌴  RGCC is sponsoring the LymeBytes® SymposiumNovember...
09/15/2026

Join us for two days on chronic inflammatory illness in November 🌴🌴

RGCC is sponsoring the LymeBytes® Symposium
November 13th -14th in Pompano Beach, FL

This Symposium is the premier functional medicine conference on complex, chronic infection-driven illnesses and the gateway to education, research, and community discourse for practitioners and scientists. Sessions cover Lyme, co-infections, environmental illness, immune dysfunction, and chronic inflammation. Friday evening: beach dinner.

Register: https://shop.lymebytes.com/?tid=8ELgVVVF9n

Address

8354 Northfield Boulevard Building G, Suite 3700
Denver, CO
80238

Alerts

Be the first to know and let us send you an email when RGCC North America posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to RGCC North America:

Sponsored

Share